Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Adalsteinsson, Jonas AWaldman, Reid
Ratner, Désirée
Feng, Hao
Tryggvadottir, Laufey
Jonasson, Jon Gunnlaugur
Issue Date
2021-05-27
Metadata
Show full item recordCitation
Adalsteinsson JA, Waldman R, Ratner D, Feng H, Tryggvadottir L, Jonasson JG. Reply to: Metformin use and keratinocyte carcinoma risk. J Am Acad Dermatol. 2021;85(4):e265. doi:10.1016/j.jaad.2021.05.028Description
To access publisher's full text version of this article click on the hyperlink belowae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2021.05.028
Scopus Count
Collections
Related articles
- Metformin use and keratinocyte carcinoma risk.
- Authors: Misitzis A, Weinstock MA
- Issue date: 2021 Oct
- The association of metformin use with keratinocyte carcinoma development in high-risk patients.
- Authors: Misitzis A, Stratigos AJ, Beatson M, Mastorakos G, Dellavalle RP, Weinstock MA, Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group.
- Issue date: 2020 Nov
- Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma.
- Authors: Misitzis A, Stratigos A, Mastorakos G, Weinstock M
- Issue date: 2022 May 1
- Systemic glucocorticoid use and early-onset basal cell carcinoma.
- Authors: Troche JR, Ferrucci LM, Cartmel B, Leffell DJ, Bale AE, Mayne ST
- Issue date: 2014 Aug
- Molecular epidemiology of basal cell carcinoma.
- Authors: Harris CC
- Issue date: 1996 Mar 20